Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUD
2776
DELISTED
Audacy, Inc.
AUD
| $144K | ﹤0.01% |
39,118
+24,378
| +165% | +$85.3K |
|
|
FLXN
2777
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $144K | ﹤0.01% |
23,666
+7,893
| +50% | +$49.2K |
|
|
STEL
2778
DELISTED
Stellar Bancorp
STEL
| $143K | ﹤0.01% |
5,399
+3,504
| +185% | +$92.9K |
|
|
MOFG
2779
DELISTED
MidWestOne Financial Group
MOFG
| $142K | ﹤0.01% |
4,723
+3,007
| +175% | +$87.8K |
|
2780
SIGA Technologies
SIGA
$219M
| $142K | ﹤0.01% |
19,242
+8,937
| +87% | +$57.3K |
|
|
AMTI
2781
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $140K | ﹤0.01% |
5,427
+2,310
| +74% | +$73.2K |
|
2782
Merchants Bancorp
MBIN
$2.49B
| $139K | ﹤0.01% |
5,286
+2,983
| +130% | +$74.2K |
|
2783
Shattuck Labs
STTK
$694M
| $139K | ﹤0.01% |
6,844
+2,890
| +73% | +$61.8K |
|
2784
Lands' End
LE
$403M
| $138K | ﹤0.01% |
5,834
+2,577
| +79% | +$88.5K |
|
2785
Ardelyx
ARDX
$997M
| $136K | ﹤0.01% |
102,900
+92,077
| +851% | +$246K |
|
2786
Victory Capital Holdings
VCTR
$6.65B
| $135K | ﹤0.01% |
3,865
+3,203
| +484% | +$107K |
|
|
WNS
2787
DELISTED
WNS Holdings
WNS
| $135K | ﹤0.01% |
1,646
-283
| -15% | -$23.1K |
|
2788
Stoke Therapeutics
STOK
$2.11B
| $134K | ﹤0.01% |
5,252
+2,532
| +93% | +$70.6K |
|
|
AMK
2789
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $133K | ﹤0.01% |
5,361
+3,580
| +201% | +$92.4K |
|
|
ORTX
2790
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $133K | ﹤0.01% |
5,787
+736
| +15% | +$21.9K |
|
|
QTNT
2791
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $133K | ﹤0.01% |
1,420
+375
| +36% | +$46.8K |
|
2792
Taysha Gene Therapies
TSHA
$1.89B
| $132K | ﹤0.01% |
7,107
+3,358
| +90% | +$63.8K |
|
|
MMAT
2793
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $132K | ﹤0.01% |
229
+164
| +252% | +$71.5K |
|
2794
Hyster-Yale Materials Handling
HY
$665M
| $131K | ﹤0.01% |
2,596
-767
| -23% | -$47.1K |
|
2795
Cullinan Oncology
CGEM
$1.14B
| $130K | ﹤0.01% |
5,744
+3,549
| +162% | +$94.9K |
|
2796
Dyne Therapeutics
DYN
$4.9B
| $129K | ﹤0.01% |
7,978
+4,577
| +135% | +$81.1K |
|
|
DFTX
2797
Definium Therapeutics
DFTX
$6.12B
| $129K | ﹤0.01% |
3,579
+137
| +4% | +$5.92K |
|
2798
Peabody Energy
BTU
$2.9B
| $128K | ﹤0.01% |
8,650
-226,013
| -96% | -$2.96M |
|
2799
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $126K | ﹤0.01% |
430
-3,270
| -88% | -$982K |
|
2800
Legend Biotech
LEGN
$4.01B
| $125K | ﹤0.01% |
2,479
| – | – |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.